As per the complaint, Satish Deshpande, one of the directors at the SII had received a message on WhatsApp from a person posing as SII CEO Adar Poonawalla and was asked to send money into seven different accounts in September 2022. Believing the message was from Poonawala, Deshpande transferred Rs 1.01 crore into those accounts, only to realise later that the company had been duped.
New Delhi [India], September 29 (ANI): The Drugs controller general of India (DCGI) allowed the export of approximately 2 lakh vaccine doses of Malaria which is produced in India, said sources on Thursday.
Pune (Maharashtra) [India], September 11 (ANI): An FIR was launched against some unidentified persons for cheating the Serum Institute of India for more than Rs. 1 crore, said the officials on Sunday.
Pune (Maharashtra) [India], August 17 (ANI): Highlighting 75 years of the US-India bilateral relationship and their cooperation on health issues, a US delegation visited the Serum Institute of India (SII) in Pune today and noted the critical role played by US-India cooperation in addressing the COVID-19 pandemic and other global health challenges.
New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has given restricted emergency use authorisation (EUA) to Pune-based Serum Institute of India's COVID-19 vaccine 'Covovax' for children aged 7 to 12 years, sources told ANI.
New Delhi [India], April 22 (ANI): British Prime Minister Boris Johnson on Friday highlighted the collaboration between Oxford-Astra Zeneca and the Serum Institute of India (SII) for the production of COVID-19 vaccines and emphasised that he has "the Indian jab" in his arms.
New Delhi [India], April 22 (ANI): Delhi government on Thursday announced that the precautionary or the booster COVID-19 dose will be available for free to all eligible beneficiaries aged between 18 and 59 years in all government vaccination centres.
New Delhi [India], April 13 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
New Delhi [India], April 12 (ANI): As some countries are presently reporting higher COVID-19 cases, Chief Executive Officer of Serum Institute of India (SII) Adar Poonawalla on Tuesday said that India is better prepared to face it now than it was in 2020.
New Delhi [India], April 12 (ANI): Chief Executive Officer (CEO) of Serum Institute of India (SII) Adar Poonawalla on Tuesday informed that the company has exported nearly 40 million COVID vaccine doses to European countries and Australia, and said that the Covovax is the first vaccine made in India to be sold in Europe.